Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Breast Neoplasms, Male × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Completed 63 Terminated 16 Unknown 5 Withdrawn 4 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 256 Carcinoma, Non-Small-Cell Lung 244 Prostatic Neoplasms 140 Colorectal Neoplasms 124 Carcinoma, Hepatocellular 123 Neoplasms 113 Leukemia, Myeloid, Acute 106 Lung Neoplasms 96 Squamous Cell Carcinoma of Head and Neck 89 Multiple Myeloma 85 Pancreatic Neoplasms 84 Triple Negative Breast Neoplasms 83 Ovarian Neoplasms 79 Recurrence 78 Stomach Neoplasms 77 Neoplasm Metastasis 70 Melanoma 63 Lymphoma, Large B-Cell, Diffuse 62 Sarcoma 58 Esophageal Neoplasms 58 Rectal Neoplasms 55 Uterine Cervical Neoplasms 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 53 Head and Neck Neoplasms 53 Glioblastoma 51 Brain Neoplasms 50 Carcinoma, Renal Cell 48 Cholangiocarcinoma 46 Endometrial Neoplasms 45 Lymphoma 43

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05501704 2026-01-07

ETHAN - ET for Male BC

Dana-Farber Cancer Institute

Phase 2 Recruiting

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡